VERONA PHARMA PLC - ADR (VRNA) Forecast, Price Target & Analyst Ratings

NASDAQ:VRNA • US9250501064

Current stock price

106.91 USD
+0.12 (+0.11%)
At close:
106.94 USD
+0.03 (+0.03%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VERONA PHARMA PLC - ADR (VRNA).

Forecast Snapshot

Consensus Price Target

Price Target
$108.43
+ 1.42% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 3, 2025
Period
Q3 / 2025
EPS Estimate
$0.27
Revenue Estimate
123.03M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
68.89%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$108.43
Upside
+ 1.42%
From current price of $106.91 to mean target of $108.43, Based on 18 analyst forecasts
Low
$101.00
Median
$109.14
High
$112.35

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

18 Wall Street analysts provided a forecast for the next 12 months for VRNA. The average price target is 108.43 USD. This implies a price increase of 1.42% is expected in the next year compared to the current price of 106.91.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

VRNA Current Analyst RatingVRNA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

VRNA Historical Analyst RatingsVRNA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
68.89%
VRNA was analyzed by 18 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about VRNA.
In the previous month the buy percentage consensus was at a similar level.
VRNA was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-07-14HC Wainwright & Co.Downgrade Buy -> Neutral
2025-07-10BTIGDowngrade Buy -> Neutral
2025-07-10Wells FargoDowngrade Overweight -> Equal-Weight
2025-07-09Canaccord GenuityDowngrade Buy -> Hold
2025-07-09JefferiesDowngrade Buy -> Hold
2025-07-01Wolfe ResearchInitiate Outperform
2025-06-23Piper SandlerMaintains Overweight -> Overweight
2025-06-20Wells FargoMaintains Overweight -> Overweight
2025-06-18Roth CapitalReiterate Buy -> Buy
2025-06-11Cantor FitzgeraldMaintains Overweight -> Overweight
2025-06-11JefferiesMaintains Buy -> Buy
2025-06-02HC Wainwright & Co.Maintains Buy -> Buy
2025-04-30Wells FargoMaintains Overweight -> Overweight
2025-04-30HC Wainwright & Co.Maintains Buy -> Buy
2025-02-28Wells FargoMaintains Overweight -> Overweight
2025-02-28HC Wainwright & Co.Maintains Buy -> Buy
2025-02-12Canaccord GenuityMaintains Buy -> Buy
2025-01-21HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-10Roth MKMInitiate Buy
2025-01-08Wells FargoMaintains Overweight -> Overweight
2025-01-08Truist SecuritiesReiterate Buy -> Buy
2024-11-05Wells FargoMaintains Overweight -> Overweight
2024-11-05Canaccord GenuityMaintains Buy -> Buy
2024-11-05HC Wainwright & Co.Maintains Buy -> Buy
2024-10-09Truist SecuritiesMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 3, 2025
Period
Q3 / 2025
EPS Estimate
$0.27
Revenue Estimate
123.03M
Revenue Q2Q
2,087.59%
EPS Q2Q
147.36%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
1.07%
EPS (1 Month)
0.00%
EPS (3 Months)
-0.55%

Next Earnings Summary

VRNA is expected to report earnings on 11/3/2025. The consensus EPS estimate for the next earnings is 0.27 USD and the consensus revenue estimate is 123.03M USD.
The next earnings revenue estimate has been revised upward by 1.07% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
VRNA revenue by date.VRNA revenue by date.
460K
-98.85%
-100.00%		42.279M427M
909.96%		753.54M
76.47%		1.159B
53.81%		1.623B
40.03%		2.144B
32.10%		2.678B
24.91%		3.206B
19.72%		3.686B
14.97%
EBITDA
YoY % growth
VRNA ebitda by date.VRNA ebitda by date.
-75.11M
-3.34%		-66.892M
10.94%		-153.569M
-129.58%		41.004M
126.70%		715.73M
1,645.51%		1.356B
89.46%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
VRNA ebit by date.VRNA ebit by date.
-75.75M
-3.33%		-67.569M
10.80%		-154.627M
-128.84%		40.418M
126.14%		263.52M
551.99%		625.73M
137.45%		958.81M
53.23%		1.362B
42.05%		1.8B
32.16%		2.208B
22.67%		2.595B
17.53%
Operating Margin
VRNA operating margin by date.VRNA operating margin by date.
-16,467.39%N/A-365.73%9.47%34.97%53.99%59.08%63.53%67.21%68.87%70.40%
EPS
YoY % growth
VRNA eps by date.VRNA eps by date.
-1.11
-14.43%		-0.68
38.74%		-2.16
-217.65%		0.52
123.97%		2.20
325.94%		5.25
138.01%		10.44
99.03%		16.76
60.45%		22.22
32.56%		28.04
26.22%		34.24
22.12%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.27
147.36%		0.19
147.60%		0.39
346.08%		0.66
406.08%		0.82
210.58%		0.88
360.71%
Revenue
Q2Q % growth		123.03M
2,087.59%		130.79M
256.81%		149.36M
95.87%		171.53M
66.31%		196.44M
59.67%		233.64M
78.64%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		26.32M
164.72%		21.884M
219.33%		46.539M
551.09%		53.386M
301.25%		86.063M
226.99%		119.24M
444.87%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VRNA Yearly Revenue VS EstimatesVRNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
VRNA Yearly EPS VS EstimatesVRNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 20 30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
64.23%
EPS Next 5 Year
57.72%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
211.05%
Revenue Next 5 Year
123.42%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
118.37%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

VERONA PHARMA PLC - ADR / VRNA Forecast FAQ

What do analysts expect the price target to be for VERONA PHARMA PLC - ADR (VRNA)?

18 analysts have analysed VRNA and the average price target is 108.43 USD. This implies a price increase of 1.42% is expected in the next year compared to the current price of 106.91.

When does VERONA PHARMA PLC - ADR (VRNA) report earnings?

VERONA PHARMA PLC - ADR (VRNA) will report earnings on 2025-11-03.

What are the consensus estimates for VERONA PHARMA PLC - ADR (VRNA) next earnings?

The consensus EPS estimate for the next earnings of VERONA PHARMA PLC - ADR (VRNA) is 0.27 USD and the consensus revenue estimate is 123.03M USD.

What is the expected long term growth rate for VRNA stock?

The expected long term growth rate for VERONA PHARMA PLC - ADR (VRNA) is 211.05%.